Luna-Mireles Y, Doubova SV, Pérez-Cuevas R

Idioma: Ingles.
Referencias bibliográficas: 50
Paginas: 330-338
Archivo PDF: 88.43 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. World Health Organization. HIV/AIDS. Key facts: 19 July 2018. Available from: http://www.who.int/news-room/fact-sheets/ detail/hiv-aids.

2. Remien RH, Rabkin JG. Psychological aspects of living with HIV disease: a primary care perspective. West J Med. 2001;175:332-5.

3. Mangili A, Murman DH, Zampini AM, Wanke CA. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort. Clin Infect Dis. 2006;42:836-42.

4. Crabtree-Ramirez B, Del Rio C, Grinsztejn B, Sierra-Madero J. HIV and noncommunicable diseases (NCDs) in Latin America: a call for an integrated and comprehensive response. J Acquir Immune Defic Syndr. 2014;67 Suppl 1:S96-8.

5. Cardona-Arias JA, Higuita-Gutierrez LF. Impact of HIV/AIDS on quality of life: meta-analysis 2002-2012. Rev Esp Salud Publica. 2014;88:87-101.

6. Kruk ME, Gage AD, Arsenault C, Jordan K, Leslie HH, Roder- DeWan S, et al. High-quality health systems in the sustainable development goals era: time for a revolution. Lancet Glob Health. 2018;6:e1196-252.

7. Ahonkhai AA, Bassett IV, Ferris TG, Freedberg KA. Improving HIV outcomes in resource-limited countries: the importance of quality indicators. BMC Health Serv Res. 2012;12:427.

8. Engelhard EA, Smit C, Nieuwkerk PT, Reiss P, Kroon FP, Brinkman K, et al. Structure and quality of outpatient care for people living with an HIV infection. AIDS Care. 2016;28:1062-72.

9. Catumbela E, Certal V, Freitas A, Costa C, Sarmento A, da Costa Pereira A, et al. Definition of a core set of quality indicators for the assessment of HIV/AIDS clinical care: a systematic review. BMC Health Serv Res. 2013;13:236.

10. Cescon AM, Cooper C, Chan K, Palmer AK, Klein MB, Machouf N, et al. Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site canadian cohort. HIV Med. 2011;12:352-60.

11. Joao EC, Gouvea MI, Menezes JA, Sidi LC, Cruz ML, Berardo PT, et al. Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil. Int J STD AIDS. 2012;23:44-7.

12. O’Connor J, Smith C, Lampe FC, Johnson MA, Chadwick DR, Nelson M, et al. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study. Lancet HIV. 2017;4:e295-302.

13. Bulage L, Ssewanyana I, Nankabirwa V, Nsubuga F, Kihembo C, Pande G, et al. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, august 2014-july 2015. BMC Infect Dis. 2017;17:326.

14. GBD 2015 HIV Collaborators. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980- 2015: the global burden of disease study 2015. Lancet HIV. 2016;3:e361-87.

15. Secretaria de Salud. Centro Nacional para la Prevencion y el Control del VIH y el SIDA (Censida). Epidemiological Surveillance of HIV/AIDS Cases in Mexico National Registry of AIDS Cases. Mexico: secretaria de Salud; 2017.

16. Gutierrez C, Lavadenz F, Macias C, Petravic J, Lavadenz L. Health, Nutrition and Population (HNP) Discussion Paper. Optimizing Investments in the National HIV Response of Mexico. Washington DC: the International Bank for Reconstruction and Development/ The World Bank; 2018.

17. Secretaria de Salud. Centro Nacional para la Prevencion y el Control del VIH y el Sida (Censida). National Report on Progress in the Response to HIV and AIDS. Mexico: secretaria de Salud; 2016.

18. Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and applying quality indicators in primary care. BMJ 2003;326:816-9.

19. Secretaria de Salud. Antiretroviral Treatment of the Adult Patient with HIV Infection. Clinical Practice Guideline. Mexico: Gobierno Federal; 2017.

20. Secretaria de Salud. Centro Nacional para la Prevencion y el Control del VIH y el SIDA (Censida). Guideline for Antiretroviral Management of People with HIV. Novena Edicion. Mexico: censida/ Secretaria de Salud; 2018.

21. U.S. Department of Health and Human Services. Health Resources and Services Administration, Guide for HIV/AIDS Clinical Care. Rockville, MD: U.S. Department of Health and Human Services; 2014.

22. DHHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Department of Health and Human Services; 2017.

23. Churchill D, Waters L, Ahmed N, Angus B, Boffito M, Bower M, et al. British HIV association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015. HIV Med. 2016;17 Suppl 4:s2-104.

24. European AIDS Clinical Society. Guidelines. Version 9. EACS; 2017. Available from: http://www.eacsociety.org/files/guidelines_9.0- english.pdf.

25. WHO Guidelines Approved by the Guidelines Review Committee. Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing HIV Infection: recommendations for a Public Health Approach. 2nd ed. Geneva: world Health Organization; 2016.

26. Polo R, Gomez-Candela C, Miralles C, Locutura J, Alvarez J, Barreiro F, et al. Recomendaciones de SPNS/GEM/SENPE/AEDN/ SEDCA/GESIDA Sobre Nutricion en el Paciente con Infeccion por VIH. Espana: ministerio de Sanidad y Consumo; 2006.

27. UNAIDS. Global AIDS Monitoring 2017. Indicators for Monitoring the 2016 United Nations Political Declaration on Ending AIDS. 2017 GUIDANCE Geneva: UNAIDS; 2017.

28. PEPFAR. President’s Emergency Plan for AIDS Relief. PEPFAR Monitoring, Evaluation, and Reporting (MER 2.0) Indicator Reference Guide; 2017. Available from: https://www.pepfar.gov/ documents/organization/263233.pdf.

29. von Wichmann MA, Locutura J, Blanco JR, Riera M, Suarez-Lozano I, Saura RM, et al. GESIDA quality care indicators for the care of persons infected by HIV/AIDS. Enferm Infecc Microbiol Clin. 2010;28 Suppl 5:6-88.

30. The Global Fund 35th Board Meeting. 2017-2022 Strategic Key Performance Indicator Framework GF/B35/07 A Revision 1. Abidjan: board Decision; 2016.

31. Valdiserri RO, Forsyth AD, Yakovchenko V, Koh HK. Measuring what matters: development of standard HIV core indicators across the U.S. Department of health and human services. Public Health Rep. 2013;128:354-9.

32. Shekelle PG, MacLean CH, Morton SC, Wenger NS. Assessing care of vulnerable elders: methods for developing quality indicators. Ann Intern Med. 2001;135:647-52.

33. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635-45.

34. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21.

35. Passin WF, Kim AS, Hutchinson AB, Crepaz N, Herbst JH, Lyles CM, et al. A systematic review of HIV partner counseling and referral services: client and provider attitudes, preferences, practices, and experiences. Sex Transm Dis. 2006;33:320-8.

36. Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr. 2006;43 Suppl 1:S149-55.

37. Harrigan PR, Hogg RS, Dong WW, Yip B, Wynhoven B, Woodward J, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191:339-47.

38. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181-3.

39. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679-90.

40. Costa JM, Torres TS, Coelho LE, Luz PM. Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the caribbean: systematic review and meta-analysis. J Int AIDS Soc. 2018; 21:e25066.

41. Duggal S, Chugh TD, Duggal AK. HIV and malnutrition: effects on immune system. Clin Dev Immunol. 2012;2012:784740.

42. Petersen M, Yiannoutsos CT, Justice A, Egger M. Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations. J Acquir Immune Defic Syndr. 2014;67 Suppl 1:S8-16.

43. Tang AM, Quick T, Chung M, Wanke CA. Nutrition assessment, counseling, and support interventions to improve health-related outcomes in people living with HIV/AIDS: a systematic review of the literature. J Acquir Immune Defic Syndr. 2015;68 Suppl 3:S340-9.

44. Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, Ram M, et al. Depression, alcohol use and adherence to antiretroviral therapy in sub-saharan Africa: a systematic review. AIDS Behav. 2012;16:2101-18.

45. Lu HF, Hsiao FH, Sheng WH, Liao SC, Wu PY, Yang YL, et al. Prevalence and predictors of depression among people living with HIV/AIDS: a National study. Nurs Res. 2018;67:379-86.

46. Wolff L C, Alvarado M R, Wolff RM. Depression in HIV infection: prevalence, risk factors and management. Rev Chilena Infectol. 2010;27:65-74.

47. Feuillet P, Lert F, Tron L, Aubriere C, Spire B, Dray-Spira R, et al. Prevalence of and factors associated with depression among people living with HIV in France. HIV Med. 2017;18:383-94.

48. World Health Organization. Factsheet on HIV-Associated Tuberculosis. WHO; 2018. Available from: https://www.who.int/tb/ areas-of-work/tb-hiv/tbhiv_factsheet.pdf?ua=1.

49. Silow-Carroll S, Edwards JN, Rodin D. Using electronic health records to improve quality and efficiency: the experiences of leading hospitals. Issue Brief (Commonw Fund). 2012;17:1-40.

50. Perez-Cuevas R, Doubova SV, Jasso-Gutierrez L, Flores-Hernandez S, Cuevas GO, Aranza-Doniz C, et al. Evaluation of the quality of care of neonates with necrotizing enterocolitis affiliated with seguro popular in Mexico. Bol Med Hosp Infant Mex. 2014;71:76-82.